1,147
Participants
Start Date
September 21, 2022
Primary Completion Date
July 24, 2024
Study Completion Date
August 21, 2024
Median LCS
End-to-end processing of chest LDCT DICOM images by an AI/ML tech-based SaMD to detect, localize, and characterize (assign a malignancy score) each detected pulmonary nodule. The output of the device is a DICOM File (Median LCS result report) summarizing results per patient.
University of Pennsylvania - Penn Center for Innovation, Philadelphia
Fundacion instituto de investigacion sanitaria de la fundacion jimenez diaz (FJD), Madrid
Universidad de Navarra, Pamplona
Baptist Clinical Research Institute, Memphis
The University of Texas M.D. Anderson Cancer Center, Houston
Lead Sponsor
Median Technologies
INDUSTRY